Your browser doesn't support javascript.
loading
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Kocatürk, Emek; Baskan, Emel Bülbül; Küçük, Özlem Su; Özdemir, Mustafa; Örnek, Sinem; Can, Pelin Kuteyla; Hasal, Eda; Engin, Burhan; Atakan, Nilgün; Alpsoy, Erkan.
Afiliação
  • Kocatürk E; Department of Dermatology, Koc University, School of Medicine, Istanbul, Turkey. Electronic address: ekocaturk@ku.edu.tr.
  • Baskan EB; Department of Dermatology, Uludag University, School of Medicine, Bursa, Turkey.
  • Küçük ÖS; Department of Dermatology, Bezmialem Vakif University, School of Medicine, Istanbul, Turkey.
  • Özdemir M; Department of Dermatology, Istanbul Medipol University, School of Medicine, Istanbul, Turkey.
  • Örnek S; Department of Dermatology, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
  • Can PK; Department of Dermatology, VM Medical Park Maltepe Hospital, Istanbul, Turkey.
  • Hasal E; Department of Dermatology, Uludag University, School of Medicine, Bursa, Turkey.
  • Engin B; Department of Dermatology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Atakan N; Department of Dermatology, Hacettepe University, School of Medicine, Ankara, Turkey.
  • Alpsoy E; Department of Dermatology, Akdeniz University, School of Medicine, Antalya, Turkey.
An Bras Dermatol ; 97(5): 592-600, 2022.
Article em En | MEDLINE | ID: mdl-35853771

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Urticária Crônica / Angioedema Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: An Bras Dermatol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Urticária Crônica / Angioedema Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: An Bras Dermatol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Espanha